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Exopolysaccharides (EPS) are extracellular carbohydrate polymers synthesized by a large variety of bacteria. Their physiological
functions have been extensively studied, but many of their roles have not yet been elucidated. We have sequenced the genomes of
two isogenic strains of Bifidobacterium animalis subsp. lactis that differ in their EPS-producing phenotype. The original strain
displays a nonmucoid appearance, and the mutant derived thereof has acquired a mucoid phenotype. The sequence analysis of
their genomes revealed a nonsynonymous mutation in the gene Balat_1410, putatively involved in the elongation of the EPS
chain. By comparing a strain fromwhich this gene had been deleted with strains containing the wild-type andmutated genes, we
were able to show that each strain displays different cell surface characteristics. The mucoid EPS synthesized by the strain har-
boring the mutation in Balat_1410 provided higher resistance to gastrointestinal conditions and increased the capability for ad-
hesion to human enterocytes. In addition, the cytokine profiles of human peripheral blood mononuclear cells and ex vivo colon
tissues suggest that the mucoid strain could have higher anti-inflammatory activity. Our findings provide relevant data on the
function of Balat_1410 and reveal that the mucoid phenotype is able to alter some of the most relevant functional properties of
the cells.
The genus Bifidobacterium includes commensal microorgan-isms commonly found in the human gut. Some strains, be-
longing mainly to the species Bifidobacterium longum, Bifido-
bacterium breve, Bifidobacterium bifidum, and Bifidobacterium
animalis, have been used as probiotics, since there is scientific
evidence that links the administration of these bacteria with spe-
cific health benefits (1, 2). In particular, B. animalis subsp. lactis
has a robust phenotype that allows growth at high numbers in
commercial applications under nonanaerobic conditions. Fur-
thermore, strains of this subspecies survive the gastric passage and
reach the intestinal tract in a metabolically active state, being also
the most common representatives of bifidobacteria in functional
food products (3). Because they are more resistant to harsh envi-
ronmental conditions, strains of B. animalis subsp. lactis have
been studied more than those of other members of the genus
Bifidobacterium, and clinical studies demonstrated their health-
promoting attributes in some gastrointestinal disorders and aller-
gic processes (4–6).
Exopolysaccharides (EPS) are extracellular layers of carbohy-
drates typically found inmicroorganisms (7). EPS production has
been involved in a variety of physiological processes that have
implications for the producer microorganism and the host (8, 9).
Specifically, in intestinal bacteria some of the most relevant roles
attributed to EPS are the favoring of intestinal colonization and
survival (10–12) and immunomodulation (11, 13, 14).
A common set of functional modules, including the synthesis
of activated sugar precursors, cytoplasmic assembly of the EPS
unit, export of the EPS repeating unit, and polymerization/chain
length determination of the final EPS skeleton, seem to be neces-
sary for EPS production (15–17). These functions are encoded in
specific gene clusters (EPS clusters) that are present in the ge-
nomes of the large majority of Bifidobacterium species; the genetic
content of these clusters is highly variable (18). Remarkably, bac-
teria can have different surface phenotypes, depending on the
presence ofmutations in the EPS genes (19). In bifidobacteria, the
particular contribution of specific genes has not yet been deter-
mined.
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In previous studies, we have shown that B. animalis subsp.
lactis strain IPLA-R1 can produce an EPS that generates a mucoid
(or ropy) phenotype. IPLA-R1 was spontaneously obtained, after
several consecutive cultures, from the strain A1dOx, which was
derived from the yogurt isolate A1 after adaptation to increasing
concentrations of ox gall (20). In the present work, we aimed to
further study our models of EPS-producing bifidobacteria (and
their polymers), and we wanted to address whether the mucoid
phenotype could be connectedwith a specific genetic background.
For that purpose, we have sequenced the genomes of mucoid and
nonmucoid strains, and we investigated more deeply the genetic
basis and the functional characteristics of this phenotype.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions.The bacterial strains
and plasmids used in this study are listed in Table 1. The bifidobacterial
strains were routinely cultivated in MRSC broth (MRS Difco [BD Biosci-
ences, SanDiego, CA] containing 0.05% L-cysteine-HCl [SigmaChemical
Co., St. Louis, MO]) at 37°C under anaerobic conditions (80% N2, 10%
CO2, 10%H2) in anMG500 chamber (DonWhitley Scientific,West York-
shire, United Kingdom). Escherichia coli strains were grown in Luria-
Bertani (LB) broth at 37°C under stirring conditions (200 rpm).
Frozen stocks (stored with 20% glycerol at80°C) were plated on the
surface of agar-MRSCor agar-LB plates, and a single colony per strainwas
used to inoculate 10ml broth. After overnight incubation, this culturewas
used to inoculate (1% vol/vol) fresh broth. Spectinomycin (100gml1),
ampicillin (100 g ml1), and erythromycin (2.5 g ml1) were added
when necessary.
Chromosomal and plasmid DNA isolation and analyses. Chromo-
somal DNA from bifidobacteria was isolated using a GenElute bacterial
genomic DNA kit (Sigma-Aldrich, Dorset, United Kingdom), according
to the manufacturer’s recommendations. The first lysis step was modified
with the addition of lysozyme (10 mg ml1) (Merck, Darmstadt, Ger-
many) andmutanolysin (5U) (Sigma-Aldrich) and additional incubation
at 37°C for 1 h. Plasmid DNA was isolated using a commercial GenElute
TABLE 1 Strains, plasmids, and oligonucleotide primers used in this study
Strain, plasmid, or oligonucleotide Description or sequence (5= to 3=) Source or reference
Strains
B. animalis subsp. lactis A1dOx Ox gall-resistant derivative, plasmid free, EPS IPLA collection (20)
B. animalis subsp. lactis IPLA-R1 Mutant of the strain A1dOx, plasmid free, EPS, mucoid phenotype IPLA collection (20)
B. animalis subsp. lactis DSM10140T Culture collection, plasmid free, EPS DSMZ collection
E. coli TG1 supE thi-1 (lac-proAB) (mcrB-hsdSM)5 (rK
mK
) F= [traD36 proAB
lacIq lacZM15]
Lucigen
E. coli DH11S mcrA (mrr-hsdRMS-mcrBC) (lac-proAB) (rec1398) deoR rpsL srl-thi-F=
proAB lacIqZM15
Invitrogen
B. lactis DSM10140-Balat_1410 DSM10140 lacking the gene Balat_1410 This work
B. lactis DSM10140-Balat_1410-pAM1
(Balat_1410 strain)
DSM10140-Balat_1410 complemented with pAM1 This work
B. lactis DSM10140-Balat_1410-pAM1-
Balat_1410 (Balat_1410 strain)
DSM10140-Balat_1410 complemented with pAM1 Balat_1410 This work
B. lactis DSM10140-Balat_1410-pAM1-
Balat_1410S89L (Balat_1410S89L strain)
DSM10140-Balat_1410 complemented with pAM1 Balat_1410S89L This work
Plasmids
pAM1 E. coli-Bifidobacterium shuttle cloning vector; Ampr Emra (23)
pAM1-Balat_1410 Gene Balat_1410 from DSM10140 in pAM1, Ampr Emr This work
pAM1-Balat_1410S89L Gene Balat_1410S89L from IPLA-R1 in pAM1, Ampr Emr This work
pJL74 E. coli-Bifidobacterium shuttle cloning vector; Ampr Spr; integrative,
nonreplicative in Bifidobacterium
(35)
pJL-dst-Balat_1410 Downstream (2.7 kb) region of the gene Balat_1410 in pJL74; Ampr Spr This work
pJL-dst/upst-Balat_1410 Upstream (3 kb) and downstream (2.7 kb) region of the gene Balat_1410 in
pJL74; Ampr Spr
This work
Oligonucleotides
Balat_1410-UPST-F tatataGGGCCCGTCACCTCGTCACCATGAGCb This work
Balat_1410-UPST-R tatataAAGCTTTAACATAGCACCGCGTGCC This work
Balat_1410-DST-F tatataGAATTCGGCACCGCTCAAGTCAGAAC This work
Balat_1410-DST-R tatataGTCGACCCACGAGAGCACACGAAGAC This work
Integration1-F CGTATGAGCGGAATCTGCAG This work
Integration1-R CACGGTACCATTTCTTGCTG This work
Integration2-F GCAGTGGCTGAATCTTCTCC This work
Integration2-R CTCGCACCTGATCTGCCTTA This work
Spec-F GGAGAAGATTCAGCCACTGC This work
Spec-R TTAGTCGTCGTATCTGAACC This work
Balat_1410KO-F GCTGGTCTCTTGCTGAATCT This work
Balat_1410KO-R CTCCTCACAGAGAGTGTTCT This work
Balat_1410pr-F GCCGACTCTAGAACATGACAGCACCTCGCTTCGTTG This work
Balat_1410pr-R GCCGACTCTAGATCATTACGATTTACGATTTTTTCTATTTTTTTCAGC This work
a Ampr, Emr, and Spr, resistance to ampicillin, erythromycin, and spectinomycin, respectively.
b Restriction enzyme sites are underlined.
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plasmid miniprep kit (Sigma-Aldrich) and a Qiagen plasmid midi kit
(Qiagen, Hilden, Germany), according to themanufacturer’s recommen-
dations. For Gram-positive strains, the first lysis step was modified as
indicated above.
Chromosomal DNA and plasmids were checked by electrophoresis in
TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA [pH 8]) on 0.8
to 1% agarose gels and then visualized with ethidium bromide staining
(0.5 g ml1). The DNA concentration was measured in a Gen5 Take3
module (BioTek, VT, USA).
DNA manipulations and molecular techniques. The PCR products
were purified using a QIAquick gel extraction kit (Qiagen). Purified plas-
mids and amplicons were sequenced at Macrogen, Inc. (Seoul, South
Korea). The Platinum TaqDNA polymerase high fidelity was from Invit-
rogen (Life Technologies, Guilford, CT). The restriction endonucleases
were supplied by Roche Diagnostics (Barcelona, Spain), and T4 DNA
ligase was obtained from Sigma-Aldrich. All reagents were used according
to the manufacturer’s instructions.
Genome sequencing and comparison of genomes. Total DNA of the
two Bifidobacterium animalis subsp. lactis strains (A1dOx and IPLA-R1)
was extracted using a GenElute bacterial genomic DNA kit (Sigma-Al-
drich), following the instructions provided by the manufacturer with a
modification of the lysis step, as indicated in “Chromosomal and plasmid
DNA isolation and analyses.” Sequencing was performed using an Illu-
mina HiSeq 2000 sequencer at Macrogen, Inc. Totals of 3,465,257,480
(A1dOx) and 3,476,287,488 (IPLA-R1) bases were sequenced, generated
by 34,309,480 (A1dOx) and 34,418,688 (IPLA-R1) paired-end reads of
101-bp average length; this resulted in a theoretical genome sequence
coverage of approximately 17-fold. More than 97% of the paired-end
reads were successfully mapped to the B. animalis subsp. lactis strain
DSM10140 complete genome sequence (RefSeq accession no. CP001606)
using Maq software (21) with the maq.pl script and the following
parameters: maq.pl easyrun -d query-genome-paired -D 2500 -E 0 -p
DSM10140.fa paired-end-file_1.fastq paired-end-file_2.fastq. Single nu-
cleotide polymorphisms (SNPs) were then identified and filtered using
the Maq option SNPfilter -q 40 -w 5 -N 2 -d 3 -D 256 -n 20 -Q 40, as
recommended for bacterial genomes (21).
Furthermore, the draft genomes of the two strains were de novo assem-
bled using Velvet sequence assembler 1.2.05 software (22), followed by
contig N50 value optimization with VelvetOptimiser 2.2.0 software (Vic-
torian Bioinformatics Consortium,Monash University). These programs
were run at the Cluster de Modelización Científica, at Oviedo University
(http://cms.uniovi.es). The final assembly results were sets of 315
(A1dOx) and 400 (IPLA-R1) unoriented contigs, with total lengths of
1,905,359 bp (A1dOx) and 1,886,812 bp (IPLA-R1).
Knockout mutant generation. The plasmid pJL74 (Table 1) was used
as the starting material for the construction of the plasmids to achieve the
knockout (KO) in B. animalis subsp. lactis DSM10140, with deletion of
the gene Balat_1410. The plasmid was constructed by cloning in two steps
the flanking regions of the gene Balat_1410 in the plasmid pJL74. The
downstream region (2.7 kb) andupstream region (3 kb)were amplified by
PCRs using the specific primers Balat_1410-DST-F/R and Balat_1410-
UPST-F/R, respectively, and the chromosomal DNA of the strain
DSM10140 was used as a template. The 2.7-kb PCR product of the down-
stream region was purified, digested with EcoRI and SalI, and purified
before cloning into pJL74, previously digested with the same enzymes and
purified from agarose gel. Ligation was performed overnight at 16°C. The
ligation mixture was purified and transformed into E. coli Tg1 competent
cells by heat shock (42°C, 2 min) to obtain the intermediate construction
pJL-dst-Balat_1410 that was verified by the use of restriction enzymes.
Similarly, the upstream region (3 kb) was inserted into the ApaI and
HindIII sites of pJL-dst-Balat_1410 and transformed into E. coliTg1 com-
petent cells to obtain the final plasmid construction pJL-dst/upst-
Balat_1410.
Then, pJL-dst/upst-Balat_1410 was electrotransformed in B. animalis
subsp. lactisDSM10140 by electroporation. The colonies grown after 72 h
in MRSC with spectinomycin (100 g ml1) were checked for plasmid
integration (single crossover) in the chromosome by PCRs using the
specific primers Integration1-F/R, Spec-F/R, and Integration2-F/R.
The bacterial cells with the integrated plasmid were grown in 10 ml
MRSC broth without antibiotics, and two subcultures per day were
grown during 5 days. Then, bacterial suspensions were plated into
agar-MRSC plates without antibiotics for 48 h. Afterwards, each col-
ony was grown on agar-MRSC plates with and without spectinomycin
to select the non-antibiotic-resistant colonies due to the looseness of
the plasmid. These colonies were checked by PCRs using the specific
primers Balat_1410KO-F/R to analyze the deletion of the Balat_1410
gene in the loop out of the plasmid. The strain lacking the gene
Balat_1410 was named DSM10140-Balat_1410.
Complementation: plasmid construction and transformation. The
pAM1 plasmid was used as the starting material to achieve the plas-
mids required for the complementation of the gene Balat_1410 in B.
animalis subsp. lactis strain DSM10140-Balat_1410. The gene Balat_1410
and its promoter were amplified by PCRs using the specific primers
Balat_1410pr-F/R and the chromosomalDNAof the strainsDSM10140
and IPLA-R1 as a template. The only difference between the two ampli-
cons was the nonsynonymous mutation in the gene Balat_1410 at po-
sition 266. The 2.5-kb PCR products were purified, digested with XbaI,
and purified before being cloned into pAM1, previously digested with
the same enzyme, and purified. Ligation was performed overnight at
16°C. Then, the ligation mixture was purified and electrotransformed
into E. coli strain DH11S electrocompetent cells to obtain the final con-
structions pAM-Balat_1410 (Balat_1410 from DSM10140) and pAM-
Balat_1410S89L (mutated Balat_1410 from IPLA-R1). The two inserts
within the twoplasmidswere sequenced to ensure that only the rightDNA
fragments had been introduced.
Both plasmids extracted from E. coli were transferred into B. animalis
subsp. lactis DSM10140-Balat_1410. The electroporation of the bifido-
bacteria was done with electrocompetent cells by electrotransformation
using a Gene Pulser apparatus (Bio-Rad Laboratories, Richmond, CA),
according to the manufacturer’s instructions. Electrocompetent B. ani-
malis subsp. lactis cells were prepared by optimizing previously reported
methods (23). In short, fresh MRSC broth (200 ml) supplemented with
0.5 M sucrose was inoculated (1% vol/vol) with an overnight culture and
incubated at 37°C for 6 to 7 h until the optical density at 600 nm (OD600)
was 0.3 to 0.5. Then, cells were chilled on ice for 10min, washed twicewith
ice-cold sucrose-citrate buffer (0.5 M sucrose, 1 mM citrate buffer [pH
6]), and resuspended in 1 ml of the same buffer. Cells were chilled on ice
for 30 min. Electrotransformation was performed at 25 F, 200, and 2
kV. Cells were immediately diluted in 1 mlMRSC broth and incubated at
37°C under anaerobic conditions for 4 h and subsequently plated on agar-
MRSC plates with erythromycin (2.5 g ml1). After 48 to 72 h, colonies
were inoculated in 10 ml MRSC broth with erythromycin, incubated for
24 to 48 h at 37°C under anaerobic conditions, and stored at80°C.
The stabilities of the original plasmid pAM1 and derivatives (pAM-
Balat_1410 and pAM-Balat_1410S89L) were assayed by growing the B.
animalis subsp. lactis transformed strains in MRSC broth without antibi-
otics for 50 generations. Then, the antibiotic resistance levels of the bac-
terial suspensions were monitored by plating them on agar-MRSC plates
with and without antibiotics (2.5 g ml1 erythromycin) and incubation
for 48 h. Finally, plasmids were monitored by plasmid extraction from
antibiotic-resistant colonies as described before.
Purification and analysis of EPS by size exclusion chromatography-
multiangle laser light scattering. The biomass of each bifidobacterial
strain, collected from the surface of at least 100 agar-MRSC plates grown
under standard conditions, was used to purify the initial crude EPS by
means of ethanol precipitation and dialysis (24). A further purification
step was carried out using sequential DNase and pronase treatments, fol-
lowed by trichloroacetic acid (TCA) precipitation, dialysis (molecular
mass cutoff of 12 to 14 kDa), and freeze-drying (25).
Purified EPS were analyzed by size exclusion chromatography (SEC)
Hidalgo-Cantabrana et al.
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coupled with multiangle laser light scattering (MALLS) detection (25).
Briefly, EPS (5 mg ml1) were dissolved in 0.1 M NaNO3 (mobile phase)
and 50l (volume injection)was separated at 40°Cwith a flow rate of 0.45
ml min1 in two TSKgel columns (G3000PWXL plus G5000PWXL), pro-
tected with a TSKgel guard column (Sigma-Aldrich). The chromatograph
(Waters, Milford, MA) had an Alliance 2690 module injector, a photo-
diode array (PDA) 996 detector (checked at 280 nm for protein detec-
tion), a 410 refraction index (RI) detector, and Empower software. Each
EPS fraction was quantified (in micrograms) with the RI detector using
the calibration equations determined with dextran standards (Sigma-Al-
drich) of different sizes (26). In addition, a third static MALLS detector
(DawnHeleos II;Wyatt Europe GmbH,Dembach, Gemany) was coupled
in series to analyze the weight-averaged molar mass (Mw) distribution of
the EPS fractions using the software Astra 3.5 (Wyatt Europe GmbH).
Adhesion to HT29 cells. The adhesion ability of B. animalis subsp.
lactis DSM10140 and derivative strains was studied with the epithelial
intestinal cell line HT29, derived from human colon adenocarcinoma.
The cell line maintenance, culture conditions, and reagents were de-
scribed elsewhere (27). For the adhesion experiments, 105 cells ml1 were
seeded in 48-well plates and incubated to confluence (monolayer of ap-
proximately 107 cells ml1), at about 13 days. Bacterial suspensions from
18-h cultures were harvested by centrifugation, washed with phosphate-
buffered saline (PBS), and resuspended in McCoy’s medium (108 cell
ml1) without antibiotics. Then, 250 l of each bacterial suspension was
added (2.5  107 bacteria), in triplicate, to the HT29 monolayer wells
(bacteria/HT29 cell ratio of 10:1), and three independent plates were as-
sayed. The plates were incubated for 1 h at 37°C in 5% CO2 in a Heracell
240 incubator (ThermoElectron LDDGmbH, Langenselbold, Germany).
Then, 250 l of each well was eliminated (containing the nonadhered
bacteria). The HT29 monolayer was broken down with the addition of
150 l (g ml1) of trypsin (Sigma-Aldrich) and 15 min of incubation at
37°C in a 5% CO2 incubator. Finally, 150 l of McCoy’s medium was
added to recovered HT29 cells, and the bacteria adhered. The number of
bacteria initially added (bacterial suspensions) and adhered to the HT29
cells was determined by counts on agar-MRSC plates. The percentage of
adhesion of each strain was calculated as follows: CFU bacteria adhered ·
100/CFU bacteria added.
PBMC stimulation and cytokine analyses. The immunomodulation
capability ofB. animalis subsp. lactisDSM10140 andderivative strainswas
determined using an in vitro model based on the cocultivation of human
peripheral blood mononuclear cells (PBMCs) with the UV-irradiated
strains in 48-well plates. The PBMCs were obtained as described by López
et al. (27). The UV-irradiated bacterial suspensions were prepared as de-
scribed by López et al. (28). The UV-irradiated bacterial suspensions in
PBS were centrifuged and resuspended in RPMI 1640 (Sigma-Aldrich)
(107 cells ml1), and 250 l was added to each well (2.5  106 bacteria
added) (bacteria/PBMC ratio of 5:1). Concanavalin A (Sigma-Aldrich)
was used as a positive control (final concentration of 10 g ml1) for
PBMC stimulation. Each factor was tested in duplicate per plate, and 8
independent plates (1 per donor) were used. Plates were incubated for 4
days at 37°C in a 5% CO2 incubator. Then, 500 l of each well was col-
lected to analyze the cytokine profile as described previously by López et
al. (27). Transforming growth factor-beta (TGF-) levels were deter-
mined using a human TGF-1 Quantikine enzyme-linked immunosor-
bent assay (ELISA) kit (R&D Systems, Abingdon, United Kingdom), fol-
lowing the manufacturer’s instructions.
Chemical simulation of the gastrointestinal transit. The survival ca-
pability of B. animalis subsp. lactis DSM10140 and derivative strains in a
chemically simulated gastrointestinal transit was analyzed using an in
vitromodelmodified from Sánchez et al. (29). In short, overnight cultures
were centrifuged, washed with PBS, and resuspended in 0.85%NaCl (109
cells ml1). These bacterial suspensions were used to inoculate 1% (vol/
vol) of a simulated gastric juice (GJ) (125 mM NaCl, 7 mM KCl, 45 mM
NaHCO3, 3 g liter
1 pepsin [Sigma-Aldrich], adjusted with HCl to pH 3)
and incubated at 37°C in aerobic conditions for 1 h. Then, bacterial sus-
pensions were centrifuged, resuspended in simulated duodenal juice (DJ)
(1% ox gall bile salts [Sigma-Aldrich], 0.1% pancreatin [Sigma-Aldrich],
adjusted with NaOH to pH 8), and incubated at 37°C in anaerobic con-
ditions for 2 h. Bacterial survival was quantified by counts on agar-MRSC
plates after 1 h of incubation in GJ and after 1 and 2 h of incubation in DJ.
The percentage of survival of each strain was calculated as follows: log
CFU bacteria recovered · 100/log CFU bacteria inoculated.
Transmission electron microscopy (TEM). Cells from a fresh over-
night culture were recovered and encapsulated in gelatin and then were
fixed in a PBS solution containing 2%glutaraldehyde and 4%paraformal-
dehyde during 3 h at room temperature. Subsequently, cells were treated
with 1%osmium tetroxide containing 0.8%potassium ferricyanide for 60
min at 4°C. Samples were dehydrated through a graded acetone series,
embedded in Epon 812 resin, and polymerized for 48 h at 60°C. Ultrathin
sections were obtained on a Leica EMUC6 ultramicrotome andmounted
on Formvar carbon-coated grids. Sections were stained with uranyl ace-
tate and lead citrate and examined in a JEOL 1011 transmission electron
microscope at 100 kV with an ES1000W Erlangshen charge-coupled de-
vice (CCD) camera.
Cryo-scanning electronmicroscopy (cryo-SEM). Strainswere grown
on the surface of agar-MRSC plates as described previously. An isolated
colony attached to the specimen holder of a CT-1000C cryo-transfer system
(Oxford Instruments, Oxford, United Kingdom) interfaced with a JEOL
JSM-5410 scanning electron microscope was picked up and frozen in N2
slush at210°C. The sample was then fractured and transferred from the
cryostage to the microscope sample stage, where the condensed surface
water was sublimated by controlled warming to 90°C. Afterwards, the
sample was transferred again to the cryostage in order to coat it with gold
by sputtering. Finally, the sample was transferred to the microscope sam-
ple stage to be viewed at an accelerating voltage of 15 keV and at5,000
magnification.
Human colonic mucosa organ culture ex vivo.Macroscopically nor-
mal colonic tissue from a distal region of resected intestine was obtained
from 5 patients after adenocarcinoma surgery. The organ culture proce-
dure was modified from Carol et al. (30). In short, colonic tissue was
washed twice with sterile phosphate buffer. Then, mucosal samples be-
tween 25 and 35 mg were separated from the colonic tissue and placed,
with the epithelial surface uppermost, on culture filter plates (15-mm-
diameter wells with 500-m bottom mesh, Netwell culture systems; Co-
star, Cambridge, MA) suspended over wells containing 1.5 ml of RPMI
1640 (Lonza BioWhittaker, Basel, Switzerland) supplemented with glu-
tamine (2 mM) and bicarbonate (100 mM) and previously incubated in
an atmosphere of 5%CO2 for 30min.Mucosal tissues were stimulated by
the addition of phorbol 12-myristate 13-acetate (PMA) (10 ng ml1)
(Sigma-Aldrich) and ionomycin (100 ng ml1) (Sigma-Aldrich) to the
RPMI 1640. Then, 100l of bifidobacterial suspensions (1010 CFUml1)
in RPMI 1640 was added on top of the tissue and cocultivated for 6 h at
37°C in an atmosphere of 5% CO2. Tissue controls without bacteria and
without bacteria and stimulation were tested in each experiment. Three
technical replicates for each experimental condition were used per donor.
After 6 h of incubation, tissues were collected in 400 l of RNAlater
(Life Technologies) for RNAextraction, in 4%paraformaldehyde (Sigma-
Aldrich) for immunohistochemistry assay, and in 1 ml phosphate buffer
for lactate dehydrogenase (LDH) measurement. Supernatants were col-
lected and stored at80°C until cytokine analyses. Levels of the cytokines
interleukin 10 (IL-10) and tumor necrosis factor-alpha (TNF-	) were
quantified using ELISA kits (human IL-10 DuoSet ELISA kit [R&D Sys-
tems] and human TNF-	 ELISA Ready-SET-Go [eBioscience, Hatfield,
United Kingdom], respectively). Bifidobacterial counts from tissue and
supernatants were obtained. Some of the mucosal tissue samples were
directly frozen at80°C without incubation as reference samples.
Tissue viability was assessed bymeasuring the LDH in the supernatant
and tissue after 6 h of incubation, according to Llopis et al. (31). Briefly,
tissue samples were homogenized in Tris-HCl (100 mmol l1, pH 7.4),
and LDH activity was analyzed by the spectrophotometric method (pyru-
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vate-lactate) recommended by the Scandinavian Society of Enzymes. The
percentage of tissue viability was calculated as follows: supernatant LDH
(units liter1)/tissue (units liter1) LDH · 100.
Nucleotide accession numbers. This whole-genome shotgun project
has been deposited in the RAST server (http://rast.nmpdr.org/) under
accession numbers 302911.15 (A1dOx strain) and 302911.16 (IPLA-R1
strain).
RESULTS AND DISCUSSION
Asinglenucleotidemutation inBalat_1410 is present in themu-
coid EPS-producingB. animalis subsp. lactis strain IPLA-R1. B.
animalis subsp. lactis IPLA-R1 displayed a mucoid phenotype
compared with that of the strain A1dOx. The strain IPLA-R1 is a
derivative of A1dOx, which, after consecutive generations, spon-
taneously acquired a mucoid phenotype (20). The sequencing of
the EPS clusters (32) (Fig. 1A) in the wild-type and the mutant
strains allowed the identification of a C to T transition in the gene
Balat_1410 at position 266, which causes a codon change. As a
consequence, a serine is substituted by a leucine in position 89
(S89L) of the protein. We sequenced the genomes of the two
strains in search of other mutations with a potential role in the
observed change of the phenotype. With the genome of the type
strain as a template (total length of the B. animalis subsp. lactis
DSM10140T genome is 1,938,483 bp; RefSeq accession no.
CP001606), the two draft genomes were compared, and the num-
ber of residues thatmatched in equivalent positions was 1,886,811
bp, corresponding to a theoretical alignment of 97.33% of the
total genomes. No other mutations were found, suggesting that
the mutated Balat_1410 gene could be involved in the acquisition
of the mucoid phenotype in IPLA-R1. These results clearly point
to a role of the gene Balat_1410 in shaping the macromolecular
structure of the EPS and, as a consequence, in the surface charac-
teristics of the cell.Mutations in the genes involved in the capsular
polysaccharide of Streptococcus pneumoniae have previously been
related to different colony morphology, i.e., rough, small, and
mucoid (19). Remarkably, it has recently been shown that muta-
tions in epsC, predicted to encode a tyrosine-protein kinase of an
EPS gene cluster and involved in the regulation of capsular EPS
biosynthesis in Lactobacillus johnsonii, cause increased levels of
EPS and the appearance of a smooth colony variant (33). In rela-
tion to this, the Balat_1410 product is a hypothetical membrane-
anchored protein with a predicted large soluble domain, theoret-
ically involved in the chain length determination of the polymer
(34) and harboring, in the mucoid strain, a serine to leucine sub-
stitution in the putative soluble part of the protein. The protein is
homologous to Etk-like tyrosine kinases, suggesting that phos-
phorylationmight regulate EPS synthesis under different environ-
mental conditions in B. animalis subsp. lactis.
Generation of recombinant B. animalis subsp. lactis strains
with different Balat_1410 backgrounds. In order to establish the
genetic bases for the acquisition of a mucoid phenotype in B.
FIG 1 (A) Physical map of the eps cluster sequenced for the strains Bifidobacterium animalis subsp. lactis A1dOx and IPLA-R1 (32) showing a single nucleotide
change in Balat_1410. (B and C) TEM (B) and cryo-SEM (C) analyses of the isogenic strains Balat_1410 (top), Balat_1410 (middle), and Balat_1410S89L
(bottom). Bars, 100 nm (B) and 10m(C). (D) SEC-MALLS analysis of EPS purified from the three isogenic strains. The blue line represents the refraction index
detection, and the red line represents the MALLS detection (angle of 90°). GTF, glucosyltransferase; P, peak; Mw (weight-averaged) molar mass.
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animalis subsp. lactis, we constructed several isogenic recombi-
nant strains. First, we removed Balat_1410 from the genome of
the type strain B. animalis subsp. lactis DSM10140 (B. lactis
DSM10140), using a knockout mutation system based on the in-
tegrative plasmid pJL74. This circular plasmid integrates into the
Bifidobacterium genome by homologous recombination through
a crossover event. Then, the integrated plasmid is lost through a
second homologous recombination event, with the concomitant
loss of the DNA sequence located between the two homologous
fragments (35, 36). In our study, this resulted in B. lactis
DSM10140-Balat_1410 (lacking the gene Balat_1410). Subse-
quently, the B. lactis strain DSM10140-Balat_1410 was comple-
mented with the plasmid pAM1 (37), yielding the B. lactis
DSM10140-Balat_1410-pAM1 (Balat_1410 strain), and with
the plasmid pAM1, containing the gene Balat_1410 with its up-
stream region (pAM1-Balat_1410), yielding B. lactis DSM10140-
Balat_1410-pAM1-Balat_1410 (Balat_1410 strain). A similar
strategy was performed using the mutated gene Balat_1410S89L,
yielding B. lactis DSM10140-Balat_1410-pAM1-Balat_1410S89L
(Balat_1410S89L strain) (for details, see Table 1; see also Fig. S1 in
the supplemental material). Although a few works have reported
gene deletion systems in Bifidobacterium longum (38, 39), to our
knowledge, this work is the first report in scientific literature of a
gene deletion system in B. animalis subsp. lactis, and it paves the
way for new opportunities to study the functional characteristics
of this commercially relevant bacteria.
B. animalis subsp. lactis Balat_1410S89L synthesizes a high-
molecular-weight polymer and displays a different cell surface.
Transmission electronmicroscopy (TEM) showed that the strains
containing Balat_1410, either the native or themutated gene, pro-
duce an outer cell surface layer which is absent in theBalat_1410
strain. On the other hand, cryo-scanning electron microscopy
(SEM) clearly differentiated the mucoid strain (Balat_1410S89L)
from the other two strains, by revealing a thick and continuous
veil covering the cell colony that was absent in the Balat_1410
and Balat_1410 strains (Fig. 1B and C). Although the two micro-
scopic techniques were not able to independently differentiate the
three strains, their combination clearly revealed differences in the
surface appearance of the three strains,most likely due to different
configurations of production and attachment of the EPS. To cor-
roborate this assumption, we performed surface EPS isolation
from the three strains and the isolated fractions were analyzed by
size exclusion chromatography coupled with a multiangle laser
light scattering detector (SEC-MALLS). Three different peaks
were consistently present in the chromatograms obtained for the
three strains. The relative abundance of each peak was different,
showing that the peak with the highest molecular weight (P1 in
Fig. 1D) was theminority fraction inBalat_1410 and Balat_1410
(accounting for 
16% of the total amount of EPS), but its pres-
ence was increased up to one-third of the total EPS amount in the
strain Balat_1410S89L. A high-molecular-weight (HMW) poly-
mer, rich in rhamnose, was also very abundant in the mucoid
strain, B. animalis subsp. lactis IPLA-R1, which contains the
Balat_1410S89L gene (32). This finding is consistent with a modi-
fied polymer mass in the strain containing the mutated gene and
suggests that Balat_1410 is involved in determining the chain
length of the EPS in B. animalis subsp. lactis.
Acid and bile resistance, as well as adhesion to intestinal
cells, is modified in the strain with the mucoid phenotype. The
strain Balat_1410S89L was able to survive the acid conditions better
than the Balat_1410 strain, and both improved their viability
comparedwith that of the strain lacking Balat_1410. A subsequent
exposure to duodenal juice containing 1%bile extract showed that
the strain containing the mutated gene behaved the best, as far as
viability was concerned, independently of the time of exposure
(Fig. 2A). These results suggest that the presence of theHMWEPS
fraction (associated with the presence of mucoid EPS) on the cell
surface could protect against gastrointestinal stress. In addition,
the potential to persist in the human gut, as affected by the differ-
ent surface properties, was approached by analyzing the adhesion
capacity with human intestinal cells. For this purpose, we have
used HT29 monolayers, which have the capability of synthesizing
mucus that could have an influence on the adhesion process (40).
The adhesion to HT29 cells was higher for the Balat_1410S89L
strain than for the Balat_1410 strain, but it was similar to the
adhesion of theBalat_1410 strain (Fig. 2B). Since the strain lack-
ing Balat_1410 has previously been shown to display a nonorga-
nized surface layer compared with those of the other two con-
FIG 2 (A) Survival of the isogenic strains Balat_1410 (white bar), Balat_1410 (light-gray bar), and Balat_1410S89L (dark-gray bar) under sequential in
vitro-simulated gastrointestinal transit. (B) Adhesion percentage of the three isogenic strains to the human colonocyte-like cell line HT29 (ratio 10:1, bacteria to
HT29). Statistical analysis: one-way analysis of variance (ANOVA) and least significant difference mean comparison test; under each condition, strains that do
not share a letter are significantly different (P
 0.05). GJ, gastric juice; DJ, duodenal juice.
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structs, this particular result suggests that in the strains containing
Balat_1410, cell surface macromolecules have lower accessibility
to the extracellular milieu. Taken together, these data may indi-
cate a favorable tendency of the cells with mucoid phenotypes to
better survive and colonize the gut.
The role of EPS in the survival and colonization ability of gut
bacteria has always been controversial. A polysaccharide utiliza-
tion locus that is conserved among intestinal Bacteroides, one of
themost abundant species in the human gutmicrobiota,mediates
stable and resilient gut colonization, and deletion of the genes
involved in polysaccharide biosynthesis results in colonization de-
fects in mice (12). Our data suggest that EPS could have an influ-
ence on survival and adhesion. However, it has been shown that
colonization and persistence characteristics of mice of two iso-
genic strains of B. breve UCC2003 producing two different extra-
cellular polymers seem to be similar. Furthermore, the lack of EPS
does produce a significantly lower persistence of the strain in
mouse cecum and colon and does not prevent colonization by the
gut pathogen Citrobacter rodentium (11). In contrast, a mutant of
L. johnsonii, with a deleted EPS biosynthesis cluster and lacking
the EPS outer layer, had an increased residence time in mice (10).
We have to bear in mind the possibility that the lack of EPS in
lactobacilli could make other molecules interact with the gut epi-
thelium, increasing the residence time (41). These results suggest
that the mechanisms governing residence time in the colon may
not be the same formembers of these two genera and highlight the
importance of knowing the structural-functional features of each
polymer in establishing ecological roles. Furthermore, the pres-
ence of pili in some species, such as B. bifidum and Lactobacillus
rhamnosus, may also play a role in adhesion (42, 43). One way or
another, our results clearly indicate the involvement ofB. animalis
subsp. lactis EPS in colonization/residence time/survival in pro-
cesses that mimic the conditions of the gastrointestinal tract.
Presence of mucoid EPS triggers the production of anti-in-
flammatory signals in PBMCs and ex vivo human colonic tis-
sues. The immunomodulatory capacity of the B. animalis subsp.
lactis strains was tested using two experimental models: in vitro
coculturewith humanperipheral bloodmononuclear cells (PBMCs)
and ex vivo coculture with ascending human colonic tissue (see
Fig. S2 in the supplemental material). The strain with the mucoid
phenotype exhibited a cytokine production pattern different from
that of the nonmucoid strains (see Tables S1 and S2 in the supple-
FIG 3 Relative amounts (concentration in the strain sample divided by the concentration in the control sample) of TNF-	 (proinflammatory cytokine) and
IL-10 (anti-inflammatory cytokine) measured in supernatants of human cells cocultivated with the isogenic strains B. lactis Balat_1410, Balat_1410, and
Balat_1410S89L. (A) In vitro coculture with PBMCs from seven healthy donors for 4 days, at a ratio of 5:1 (UV-inactivated bacteria to PBMCs) (control samples
in RPMI medium). (B) Ex vivo coculture with ascending colonic tissue (from the healthy tissue of five cancer patients) for 6 h (bifidobacteria added at about 1
 109 CFU/sample) (control samples in RPMI medium). The ratio TNF-	/IL-10 was calculated to determine the potential anti-inflammatory profile of the
strains under study. Box and whiskers show median, interquartile range (25% percentile and 75% percentile), and minimum and maximum values. Statistical
analysis: nonparametric Mann-Whitney test; strains that do not share a letter are significantly different (P
 0.05).
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mental material). The production of the anti-inflammatory
cytokine IL-10 was significantly higher when the mucoid strain
Balat_1410S89L was cocultivated in vitrowith human PBMCs (Fig.
3A), and significantly lower production of TNF-	 was measured
after cocultivation with colonic biopsy specimens (Fig. 3B) in the
mucoid strain compared with that for the strain containing the
wild-type Balat_1410 gene. A low TNF-	/IL-10 ratio has been
used as an indicator of the anti-inflammatory capacity of some
bacteria and antigens (28). Overall, the TNF-	/IL-10 ratio was
lower for the Balat_1410S89L strain than for the Balat_1410 and
Balat_1410 strains. This differencewas, however, not statistically
significant between the Balat_1410 and Balat_1410S89L strains
using ex vivo viable colon tissues. Several immune system-stimu-
lating capabilities were associated with different Bifidobacterium
strains, some of which show proinflammatory profiles, whereas
others display potential anti-inflammatory activity (28, 42, 44).
However, in very few cases has the immunological effect of bifi-
dobacteria been associated with the presence of EPS. In B. breve
UCC2003, EPS-producing variants failed to elicit a strong im-
mune response compared with that for nonproducing ones (11).
In Lactobacillus rhamnosus GG, it has been suggested that EPS
form a protective shield against host innate immune molecules in
the intestine (13). In other commensal bacteria, such as Bacte-
roides fragilis, the extracellular polysaccharide A mediates a regu-
latory T cell (Treg) response that triggers production of IL-10
during commensal colonization (45). In relation to this, Hidalgo-
Cantabrana and coworkers (46) highlighted the effect of the ex-
perimental models (in vivo versus in vitro) on their results, thus
calling for caution when results obtained with different cell
/animal models are compared.
In conclusion,most bifidobacteria contain EPS gene clusters in
their genomes (18, 47), but the functional roles of the enzymatic
machinery responsible for the synthesis of the EPS and of the
polymers themselves are largely unknown. In our study, we have
demonstrated that Balat_1410 is not essential for EPS production
in B. animalis subsp. lactis. However, two variants of this gene
confer different surface properties and phenotypic characteristics.
The mucoid phenotype, most likely due to a larger abundance of
an HMWEPS, is able to alter some of the most relevant intestinal
colonization and persistence properties of the cells, as well as their
immune system-stimulating capability. Further experiments are
required to determine if these phenotypes confer an adaptive ad-
vantage to the mucoid strains and if the mucoid phenotype con-
stitutes a positive selection criterion of B. animalis subsp. lactis
strains intended to be used as probiotics.
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